DEXAMETHASONE / LEVOFLOXACIN EYE DROPS (Ducressa®)
Clinical Indication
Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults.
Date of classification
July 2022
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.